Kronox Lab Sciences Limited (BOM:544187)
India · Delayed Price · Currency is INR 216.05
+29.70 (15.94%)
At close: Aug 21, 2026
Kronox Lab Sciences Ratios and Metrics
Market cap in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Total Valuation
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 20, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 7,984 | 3,600 | 5,323 | - | - | - | |
Market Cap Growth | 28.66% | -32.38% | - | - | - | - |
Enterprise Value | 7,513 | 3,104 | 5,129 | - | - | - |
Last Close Price | 216.05 | 97.60 | 143.43 | - | - | - |
Price Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 20, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
PE Ratio | 27.83 | 13.02 | 20.90 | - | - | - |
PS Ratio | 7.58 | 3.56 | 5.31 | - | - | - |
PB Ratio | 6.88 | 3.10 | 5.91 | - | - | - |
P/TBV Ratio | 6.88 | 3.10 | 5.91 | - | - | - |
P/FCF Ratio | 38.78 | 17.49 | 19.29 | - | - | - |
P/OCF Ratio | 33.42 | 15.07 | 17.34 | - | - | - |
EV Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 20, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
EV/Sales Ratio | 7.13 | 3.07 | 5.12 | - | - | - |
EV/EBITDA Ratio | 21.20 | 9.06 | 15.33 | - | - | - |
EV/EBIT Ratio | 22.63 | 9.63 | 15.93 | - | - | - |
EV/FCF Ratio | 36.50 | 15.08 | 18.59 | - | - | - |
Financial Efficiency
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 20, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Debt / Equity Ratio | 0.01 | 0.01 | - | - | - | 0.08 |
Debt / EBITDA Ratio | 0.04 | 0.05 | - | - | - | 0.17 |
Debt / FCF Ratio | - | 0.08 | - | - | - | 0.64 |
Net Debt / Equity Ratio | -0.41 | -0.41 | -0.40 | -0.22 | -0.13 | -0.16 |
Net Debt / EBITDA Ratio | -1.31 | -1.37 | -1.07 | -0.50 | -0.26 | -0.35 |
Net Debt / FCF Ratio | - | -2.29 | -1.30 | -2.80 | -0.50 | -1.27 |
Asset Turnover | - | 0.89 | 1.16 | 1.40 | 1.73 | 1.75 |
Inventory Turnover | - | 6.32 | 6.57 | 5.02 | 6.62 | 7.34 |
Quick Ratio | - | 6.74 | 6.47 | 4.76 | 2.84 | 2.62 |
Current Ratio | - | 7.61 | 7.28 | 6.08 | 3.89 | 3.21 |
Return on Equity (ROE) | - | 26.82% | 32.56% | 38.45% | 38.55% | 40.58% |
Return on Assets (ROA) | - | 17.79% | 23.29% | 26.73% | 23.11% | 23.95% |
Return on Invested Capital (ROIC) | 36.15% | 38.78% | 45.08% | 44.90% | 41.88% | 45.11% |
Return on Capital Employed (ROCE) | - | 27.50% | 35.70% | 41.30% | 45.30% | 42.10% |
Yields
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 20, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Earnings Yield | 3.59% | 7.68% | 4.78% | - | - | - |
FCF Yield | 2.58% | 5.72% | 5.18% | - | - | - |
Dividend Yield | 0.23% | 0.51% | 0.35% | - | - | - |
Payout Ratio | - | 6.71% | 7.28% | - | - | - |
Buyback Yield / Dilution | 1.09% | 0.74% | - | 4.09% | 0.91% | 3.59% |
Total Shareholder Return | 1.32% | 1.25% | 0.35% | 4.09% | 0.91% | 3.59% |